Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Bioceres Crop Solutions (BIOX) Shares Outstanding (2019 - 2025)

Bioceres Crop Solutions' Shares Outstanding history spans 6 years, with the latest figure at $63.2 million for Q2 2025.

  • On a quarterly basis, Shares Outstanding rose 0.6% to $63.2 million in Q2 2025 year-over-year; TTM through Jun 2025 was $63.2 million, a 0.6% increase, with the full-year FY2025 number at $63.2 million, up 0.6% from a year prior.
  • Shares Outstanding hit $63.2 million in Q2 2025 for Bioceres Crop Solutions, up from $62.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding for BIOX hit a ceiling of $63.2 million in Q2 2025 and a floor of $176229.0 in Q2 2021.
  • Historically, Shares Outstanding has averaged $31.6 million across 5 years, with a median of $31.5 million in 2022.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 25928.83% in 2022 and later increased 0.08% in 2024.
  • Tracing BIOX's Shares Outstanding over 5 years: stood at $182224.0 in 2021, then surged by 25072.51% to $45.9 million in 2022, then surged by 36.9% to $62.8 million in 2023, then increased by 0.08% to $62.8 million in 2024, then rose by 0.6% to $63.2 million in 2025.
  • Business Quant data shows Shares Outstanding for BIOX at $63.2 million in Q2 2025, $62.8 million in Q2 2024, and $62.8 million in Q2 2023.